Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.23.3
Stockholders’ Equity (Tables)
3 Months Ended
Oct. 31, 2023
Stockholders’ Equity [Abstract]  
Schedule of Share-based Compensation Expense The amounts of share-based compensation expense recognized in the periods presented are as follows:
    Three months ended
October 31,
 
    2023     2022  
Stock options and performance stock units   $ 646       180  
Restricted stock units     429       186  
    $ 1,075       366  
The following table sets forth the amount of expense related to share-based payment arrangements included in specific line items in the accompanying statements of operations:
    Three months ended
October 31,
 
    2023     2022  
Selling, general and administrative   $ 1,069       360  
Cost of revenues     6       6  
    $ 1,075       366  
Schedule of Stock Option Activity The following table summarizes stock option activity during the three month period ended October 31, 2023:
     Options         Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term
    Aggregate
Intrinsic
Value
(000s)
 
Outstanding at July 31, 2023     3,829,500     $ 2.61                
Granted                          
Exercised                       $    
Cancelled or expired     (508,916 )   $ 1.58                  
Outstanding at end of period     3,320,584     $ 2.64        2.5 years       $  
Exercisable at end of period     2,313,784     $ 2.83        1.9 years       $  
Schedule of Summarizes Restricted Stock Unit (“RSU”) Activity The following table summarizes RSU activity for the three months ended October 31, 2023:
    Number of 
RSUs 
outstanding
    Weighted
Average Fair
Value per
Unit at
Date of
Grant
    Weighted
Average
Remaining
Contractual
Term
    Aggregate
Intrinsic
Value (000s)
 
Outstanding at beginning of fiscal year     557,490     $ 2.21       1.1 years       825  
Granted         $                
Vested     (173,333 )   $ 3.39                  
Cancelled     (100,000   $ 1.97                  
Outstanding at end of period     284,157     $ 1.75       0.4 years     $ 381  
Expected to vest at end of period     284,157     $ 1.75       0.4 years     $ 381